PharmEasy’s Valuation Plummets by 92% from Peak nextdigitalhealth.com

An online pharmacy known as PharmEasy has had a decline of its valuation to $45.6 million from the previous high of $560 million. This is also a drop of 18.57% from its last fundraising value in April 2024, when the company was valued at $560 million.

This emerged after TechCrunch reported that PharmEasy’s valuation had declined, as per its investor, Janus Henderson. Specifically, the investor said that its 12.9 million shares—which the company sold for $9.4 million—are now worth only $0.76 million.